1 Marijuana Company Setting Strong Roots in the U.S.

MedMen Enterprises Inc (CNSX:MMEN) is extending its presence in several key markets south of the border, but is the pot company a buy?

| More on:
edit Cannabis leaves of a plant on a dark background

Image source: Getty Images

The cannabis market has come a long way in Canada. Over the past two years, sales and revenues have skyrocketed, and this upward trend will likely continue. This makes Canada a particularly attractive target for pot companies and investors looking to make a buck. However, the market south of the border promises to be even larger. Indeed, the state of California alone could rack up sales that will eclipse those of Canada. With that in mind, let’s look at a cannabis company with strong footprints in the Golden State and elsewhere in the U.S.: MedMen Enterprises (CNSX:MMEN). 

Retail presence in California 

MedMen has a very clear strategy in mind, and one of the firm’s top priorities is to build a solid brand name. The pot company intends to do so by entering top markets. No wonder, then, that MedMen chose California, which was the first U.S. state to legalize medical uses of marijuana and is currently one of about a dozen states that have legalized recreational uses as well. California is also the largest U.S. state by population (by a notable margin) and is even more populated than Canada. Thus, the Golden State presents golden opportunities to pot companies. 

MedMen argues that various cannabis regulations and restrictions create somewhat of a barrier to entry in the industry. For instance, there is a limited number of licences available to be issued to retailers. Further, in the state of California, cannabis retail stores must (by law) be located a certain distance away from schools, churches, other cannabis retail stores, etc. These factors make it much harder for new pot companies to move in once others have already established a presence. Since MedMen already possesses solid footprints in the state (with 11 retail stores), the firm is at an advantage. 

Moving into the sunshine state

California isn’t the only state in which MedMen has set up shop. The company has also entered the state of Illinois. In case you don’t remember, Illinois recently became the latest state to legalize recreational uses of marijuana. The Midwestern state presents another interesting opportunity for cannabis companies. Last year, MedMen announced an agreement to acquire PharmaCann, one of the largest medical cannabis operators in the state. PharmaCann currently serves an overwhelming majority of patients in Chicago, the largest city in Illinois. 

Once the regulatory review closes, MedMen will acquire PharmaCann’s 10 retail stores, which should serve as a nice springboard for its operations in Illinois. MedMen is also present in other states, including Arizona (three locations), Nevada (three locations), and New York (four locations). However, the firm is currently establishing strong footprints in Florida. MedMen already possesses two retail locations in the sunshine state, but the firm expects to open about 10 more in the near future. This would make Florida — the fourth-largest state by population and one in which medical uses of marijuana are legal — one of MedMen’s most important markets. 

Setting the stage for the future

MedMen is still a relatively small and unprofitable corporation. But then again, that’s true for many companies in the marijuana sector. The firm’s effort to build a strong presence in some of the largest markets in the U.S., though, could pay rich dividends in the future. Of course, a lot would have to go right for that to happen, and now is probably a bit too soon to jump aboard this ship, especially since its expenses and costs have increasing at a frenetic pace. However, it would be wise to keep an eye on MedMen Enterprises. 

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Prosper Bakiny has no position in any of the stocks mentioned.  

More on Cannabis Stocks

A cannabis plant grows.
Cannabis Stocks

Canopy Growth Stock Is Rising But I’m Worried About This One Thing

Canopy Growth stock is soaring as the legalization effort makes real progress in both Germany and the United States.

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

Why Canopy Growth Stock Could Double in 2024

Canopy Growth (TSX:WEED) stock saw its share more than double in the last two weeks. So, can it do it…

Read more »

Coworkers standing near a wall
Cannabis Stocks

Why Is Everyone Talking About Canopy Growth Stock?

Canopy Growth stock (TSX:WEED) saw shares surge in the last two weeks for a variety of reasons investors can dig…

Read more »

Pot stocks are a riskier investment
Stocks for Beginners

Why Shares of Cannabis Stocks Are Rising This Week

Cannabis stocks received a boost this week as the White House urged the drug enforcement administration to reschedule the drug.

Read more »

A person holds a small glass jar of marijuana.
Stocks for Beginners

Why Canopy Growth Stock Jumped 16% on Wednesday

Canopy Growth stock (TSX:WEED) is up 16% on Wednesday, adding to a surge of 60% growth in the last week…

Read more »

Pot stocks are a riskier investment
Cannabis Stocks

Is the Worst Over for Canopy Growth Stock?

Down 99% from all-time highs Canopy Growth stock has burnt investor wealth and remains a high-risk investment.

Read more »

Pot stocks are a riskier investment
Cannabis Stocks

Steer Clear: This Stock Spells Trouble

A newly listed cannabis stock is outperforming in 2024 but investors should stay clear to avoid trouble and losses.

Read more »

Cannabis stocks have fallen.
Cannabis Stocks

2 Best Marijuana Stocks to Buy This Month

Marijuana stocks in the U.S. such as Green Thumb and Curaleaf can help you deliver outsized gains to investors in…

Read more »